Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech By: Benzinga via Benzinga October 05, 2017 at 07:40 AM EDT On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options volume in SPDR S&P Biotech (ETF) (NYSE: ... Read More >> Related Stocks: S&P Biotech SPDR